The Effect of Exchange Transfusion on Prooxidant-Antioxidant Balance

To Investigate the Effect of Exchange Transfusion on Prooxidant-Antioxidant Balance (PAB) in Newborns Jaundice

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016112812197N6

Enrollment

Registered

2016-12-24

Start date

2014-07-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia. Neonatal jaundice associated with preterm delivery

Interventions

Blood Exchange.

Treatment - Other

Blood Exchange

Eligibility

Sex/Gender

All

Age

2 Days to 10 Days

Inclusion criteria

Inclusion criteria: In this study, the newborns to term and near-term (over 35 weeks) were selected with available sampling. The newborns were enrolled studied after the consent of the parents. Exclusion criteria for studying included severe birth defects; birth asphyxia; respiratory distress; even mild or transient; sepsis; Rh incompatibility and ABO; direct Coombs test positive; maternal diabetes and preeclampsia / eclampsia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Prooxidant-Antioxidant Balance (PAB). Timepoint: before, after and 6 hours after the exchange transfusion. Method of measurement: Prooxidant-Antioxidant Balance is considered by TMB in two different reactions.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Zakerihamidi

Tonekabon Islamic Azad University

maryamzakerihamidi@yahoo.co.nz+98 11 5224 5014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026